FOOD AND DRUG ADMINISTRATION MK r NOTICES OF JUDGMENT UNDER THE FEDERAL FOOD, DRUG, AND COSMETIC ACT [Given pursuant to section 705 of the Food, Drug, and Cosmetic Act] 3821-3840 DRUGS AND DEVICES The cases reported herewith were instituted in the United States district courts by the United States attorneys, acting upon reports submitted by the Federal Security Agency. Published by direction of the Federal Security Administrator. CHABLES W. CBAWFOBD, Commissioner of Food and Drugs, WASHINGTON, D. C, March 16,1953. CONTENTS * Page Drugs in violation of prescription labeling lequirements 312 Drugs actionable because of failure to bear adequate directions or warning statements 312 Drugs and devices actionable because of deviation from official or own standards 318 Page Drugs actionable because of false and misleading claims 322 Drugs for human use 322 Drugs for veterinary use 324 Index 326- *For presence of a habit-forming narcotic without warning statement, see Nos. 3822-3824, 3826-3828"; omission of, or unsatisfactory, ingredients statements, Nos. 3822-3826; imitation of, and sale under name of, another drug, No. 3830; failure to bear a label containing an accurate statement of the quantity of the con- tents, Nos. 3822-3828; failure to bear a label containing the name and place of business of the manufacturer, packer, or distributor, Nos. 3822-3827. 311 242335-53 1 DRUGS IN VIOLATION OF PRESCRIPTION LABELING REQUIREMENTS 3821. Misbranding of male hormone tablets. U. S. y. 719 Boxes, etc. (F. D. C. No. 33331. Sample Nos. 34692-L, 34693-L.) July 19, 1952, Western District of Arkansas. ?MENT; On or about May 29, 1952, by Captivante Laboratories, from NW^ork, N. Y. PRODUCT : l,3TT^60-tablet boxes of male hormone tablets at Hot Springs, Ark. LABEL, IN PART4 (Box) "Yale Testrex Male Sex Hormones 60 Tablets * * . * Ingredients per tablet 2.5 mg. Metbyl Testosterone witb Ethinyl Estradiol .0025 mg." and "Yale Testrex Male Sex Hormones 60 Tablets- Super-Strength (Double Potency) * * * Ingredients per tablet 5 mg. Methyl Testosterone with Ethinyl Estradiol .0050 mg." NATURE OF CHARGE: Misbranding, Section 503 (b) (4), the tablets were in- tended for use by man and were subject to Section 503 (b) (1) (B), and the labels of the tablets failed to bear the statement "Caution: Federal Law prohibits dispensing without prescription." DISPOSITION : September 23, 1952. Default decree of condemnation and de- struction. DRUGS ACTIONABLE BECAUSE OF FAILURE TO BEAR ADEQUATE DIRECTIONS OR WARNING STATEMENTS